Shimshoni E., Adir I., Afik R., Solomonov I., Shenoy A., Adler M., Puricelli L., Sabino F., Savickas S., Mouhadeb O., Gluck N., Fishman S., Werner L., Salame T., Shouval D. S., Varol C., auf dem Keller U., Podestà A., Geiger T., Milani P., Alon U. & Sagi I. (2021).
Distinct extracellularmatrix remodeling events precede symptoms of inflammation.Matrix Biology.2021 Feb
,
96
:47-68.
Kult S., Olender T., Osterwalder M., Markman S., Leshkowitz D., Krief S., Blecher-Gonen R., Ben-Moshe S., Farack L., Keren-Shaul H., Salame T. M., Capellini T. D., Itzkovitz S., Amit I., Visel A. & Zelzer E. (2021).
Bi-fated tendon-to-bone attachment cells are regulated by shared enhancers and KLF transcription factors.eLife.2021 Jan 15
,
10
:1-29.
Marrocco I., Romaniello D., Vaknin I., DragoGarcia D., Oren R., Uribe M. L., Belugali Nataraj N., Ghosh S., Eilam R., Salame T., Lindzen M. & Yarden Y. (2021).
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.EMBO Molecular Medicine.2021 Mar 4
,
13
(4).
Pewzner-Jung Y., Joseph T., Blumenreich S., Vardi A., Ferreira N. S., Cho S. M., Eilam R., Tsoory M., Biton I. E., Brumfeld V., Haffner-Krausz R., Brenner O., Sharabi N., Addadi Y., Salame T. M., Rotkopf R., Wigoda N., Yayon N., Merrill A. H., Schiffmann R. & Futerman A. H. (2021).
Brain pathology and cerebellar purkinje cell loss in a mouse model of chronic neuronopathic Gaucher disease.Progress in Neurobiology.2021 Feb
,
197
.
Ben-Yehuda H., Arad M., Peralta Ramos J. M., Sharon E., Castellani G., Ferrera S., Cahalon L., Colaiuta S. P., Salame T. & Schwartz M. (2021).
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.Molecular Neurodegeneration.2021 Jun 25
,
16
(1).
Giladi A., Cohen M., Medaglia C., Baran Y., Li B., Zada M., Bost P., Blecher-Gonen R., Salame T., Mayer J. U., David E., Ronchese F., Tanay A. & Amit I. (2020).
Dissecting cellular crosstalk by sequencing physically interacting cells.Nature Biotechnology.2020 May 1
,
38
(5):629-637.
Dosoretz C. G., Salame T. M. & Hadar Y. (2020).
Lignin-degrading fungi..2020,
.
Elhanani O., Salame T. M., Sobel J., Leshkowitz D., Povodovski L., Vaknin I., Kolodkin-Gal D. & Walker M. D. (2020).
REST Inhibits Direct Reprogramming of Pancreatic Exocrine to Endocrine Cells by Preventing PDX1-Mediated Activation of Endocrine Genes.Cell Reports.2020 May 5
,
31
.
Fuzesi-Levi M. G., Fainer I., Enchev R. I., Ben-Nissan G., Levin Y., Kupervaser M., Friedlander G., Salame T. M., Nevo R., Peter M. & Sharon M. (2020).
CSNAP, the smallest CSN subunit, modulates proteostasis through cullin-RING ubiquitin ligases.Cell Death and Differentiation.2020 Mar
,
27
(3):984-998.
Lahav-Mankovski N., Prasad P. K., Oppenheimer-Low N., Raviv G., Dadosh T., Unger T., Salame T. M., Motiei L. & Margulies D. (2020).
Decorating bacteria with self-assembled synthetic receptors.Nature Communications.2020 Mar 10
,
11
(1).
Katzenelenbogen Y., Sheban F., Yalin A., Yofe I., Svetlichnyy D., Jaitin D. A., Bornstein C., Moshe A., Keren-Shaul H., Cohen M., Wang S., Li B., David E., Salame T., Weiner A. & Amit I. (2020).
Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer.Cell.2020 Aug 20
,
182
(4):872-885.e19.
Gross-Vered M., Trzebanski S., Shemer A., Bernshtein B., Curato C., Stelzer G., Salame T., David E., Boura-Halfon S., Chappell-Maor L., Leshkowitz D. & Jung S. (2020).
Defining murine monocyte differentiation into colonic and ileal macrophages.eLife.2020 Jan 8
,
9
.
Kolodziejczyk A. A., Federici S., Zmora N., Mohapatra G., Dori-Bachash M., Hornstein S., Leshem A., Reuveni D., Zigmond E., Tobar A., Salame T. M., Harmelin A., Shlomai A., Shapiro H., Amit I. & Elinav E. (2020).
Acute liver failure is regulated by MYC- and microbiome-dependent programs.Nature Medicine.2020 Oct 26
,
26
(12):1899-1911.
Gross-Vered M., Shmuel-Galia L., Zarmi B., Humphries F., Thaiss C., Salame T., David E., Chappell-Maor L., Fitzgerald K. A., Shai Y. & Jung S. (2020).
TLR2 Dimerization Blockade Allows Generation of Homeostatic Intestinal Macrophages under Acute Colitis Challenge.Journal of Immunology.2020 Feb 1
,
204
(3):707-717.
Feldman T., Grossman-Haham I., Elkis Y., Vilela P., Moskovits N., Barshack I., Salame T. M., Fass D. & Ilani T. (2020).
Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models.Oncotarget.2020 Jan 28
,
11
(4):386-398.
Blecher-Gonen R., Bost P., Hilligan K. L., David E., Salame T. M., Roussel E., Connor L. M., Mayer J. U., Halpern K. B., Toth B., Itzkovitz S., Schwikowski B., Ronchese F. & Amit I. (2019).
Single-Cell Analysis of Diverse Pathogen Responses Defines a Molecular Roadmap for Generating Antigen-Specific Immunity.Cell Systems.2019 Feb 27
,
8
(2):109-121.e6.
Eyal S., Kult S., Rubin S., Krief S., Felsenthal N., Pineault K. M., Leshkowitz D., Salame T., Addadi Y., Wellik D. M. & Zelzer E. (2019).
Bone morphology is regulated modularly by global and regional genetic programs.Development.2019 Jul 26
,
146
(14).
Oclon E., Solomon G., Hayouka Z., Salame T. M., Goffin V. & Gertler A. (2018).
Novel reagents for human prolactin research: Large-scale preparation and characterization of prolactin receptor extracellular domain, non-pegylated and pegylated prolactin and prolactin receptor antagonist.Protein Engineering, Design and Selection.2018 Jan
,
31
(1):7-16.
Romaniello D., Mazzeo L., Mancini M., Marrocco I., Noronha A., Kreitman M., Srivastava S., Ghosh S., Lindzen M., Salame T. M., Onn A., Bar J. & Yarden Y. (2018).
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways.Clinical Cancer Research.2018 Nov 15
,
24
(22):5610-5621.
Mancini M., Gal H., Gaborit N., Mazzeo L., Romaniello D., Salame T. M., Lindzen M., Mahlknecht G., Enuka Y., Burton D. G. A., Roth L., Noronha A., Marrocco I., Adreka D., Altstadter R. E., Bousquet E., Downward J., Maraver A., Krizhanovsky V. & Yarden Y. (2018).
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.EMBO Molecular Medicine.2018 Feb
,
10
(2):294-308.
